MedTrace Logo

Measurement of HIV Risk to Create Demand for Safe Male Circumcision

NCT02775357 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 968

Last updated 2016-05-17

No results posted yet for this study

Summary

The study is aimed at testing whether use of a new index to measure risk for HIV in the context of HIV testing and counseling will increase demand for safe male circumcision (SMC) services among HIV-negative non-muslim men in Rakai. We will also study whether use of the index leads to positive sexual behavioral modifications among men. The study will also measure acceptability of the index among men.

Conditions

Interventions

BEHAVIORAL

Measurement and communication of HIV risk

Measurement and communication of HIV risk in the context of HIV testing and counseling to inform HIV risk reduction counseling

BEHAVIORAL

Standard HIV testing and counseling

Participants received HIV testing and counseling following standard Ministry of Health guidelines

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    collaborator OTHER

  • Makerere University

    collaborator OTHER

  • Rakai Health Sciences Program

    lead OTHER

Principal Investigators

  • Joseph Kagaayi, Ph.D · Rakai Health Sciences Program

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02775357 on ClinicalTrials.gov